Broad‐spectrum and sensitive screening of more than 1000 compounds in equine urine using liquid chromatography/high‐resolution mass spectrometry

Rationale To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine. Methods The procedure involved the e...

Full description

Saved in:
Bibliographic Details
Published inRapid communications in mass spectrometry Vol. 38; no. 17; pp. 1 - 1593
Main Authors Uchida, Taiga, Kisugi, Takaya, Ishii, Hideaki, Yamada, Masayuki, Kinoshita, Kenji, Leung, Gary Ngai‐Wa
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 15.09.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Rationale To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine. Methods The procedure involved the enzymatic hydrolysis of 3 mL urine samples followed by solid‐phase extraction using HF Bond Elut C18 cartridge. The resulting extracts were then separated on a C18 reversed‐phase column and analyzed using liquid chromatography/high‐resolution mass spectrometry (LC/HRMS) in both electrospray ionization positive and negative modes in two separate injections. The analytical data were obtained in full scan and product ion scan (PIS) modes in an 11 min LC run. Results The method can detect 1011 compounds (in both positive and negative ion modes). Over 95% of the target compounds have limits of detections (LODs) ≤10 ng/mL, and more than 50% of the LODs are ≤0.5 ng/mL. The lowest LOD can reach down to 0.01 ng/mL. The applicability of the method was demonstrated by the successful detection of prohibited substances in overseas and domestic equine urine samples. Conclusions We have successfully developed a regular screening method for equine urine samples that can detect more than 1000 compounds at sub‐ppb levels in both positive and negative ion modes with full scan and PIS using LC/HRMS. Furthermore, this method can theoretically be expanded to accommodate an unlimited number of prohibited substances in full‐scan mode.
AbstractList To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine. The procedure involved the enzymatic hydrolysis of 3 mL urine samples followed by solid-phase extraction using HF Bond Elut C18 cartridge. The resulting extracts were then separated on a C18 reversed-phase column and analyzed using liquid chromatography/high-resolution mass spectrometry (LC/HRMS) in both electrospray ionization positive and negative modes in two separate injections. The analytical data were obtained in full scan and product ion scan (PIS) modes in an 11 min LC run. The method can detect 1011 compounds (in both positive and negative ion modes). Over 95% of the target compounds have limits of detections (LODs) ≤10 ng/mL, and more than 50% of the LODs are ≤0.5 ng/mL. The lowest LOD can reach down to 0.01 ng/mL. The applicability of the method was demonstrated by the successful detection of prohibited substances in overseas and domestic equine urine samples. We have successfully developed a regular screening method for equine urine samples that can detect more than 1000 compounds at sub-ppb levels in both positive and negative ion modes with full scan and PIS using LC/HRMS. Furthermore, this method can theoretically be expanded to accommodate an unlimited number of prohibited substances in full-scan mode.
Rationale To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine. Methods The procedure involved the enzymatic hydrolysis of 3 mL urine samples followed by solid‐phase extraction using HF Bond Elut C18 cartridge. The resulting extracts were then separated on a C18 reversed‐phase column and analyzed using liquid chromatography/high‐resolution mass spectrometry (LC/HRMS) in both electrospray ionization positive and negative modes in two separate injections. The analytical data were obtained in full scan and product ion scan (PIS) modes in an 11 min LC run. Results The method can detect 1011 compounds (in both positive and negative ion modes). Over 95% of the target compounds have limits of detections (LODs) ≤10 ng/mL, and more than 50% of the LODs are ≤0.5 ng/mL. The lowest LOD can reach down to 0.01 ng/mL. The applicability of the method was demonstrated by the successful detection of prohibited substances in overseas and domestic equine urine samples. Conclusions We have successfully developed a regular screening method for equine urine samples that can detect more than 1000 compounds at sub‐ppb levels in both positive and negative ion modes with full scan and PIS using LC/HRMS. Furthermore, this method can theoretically be expanded to accommodate an unlimited number of prohibited substances in full‐scan mode.
To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine.RATIONALETo uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine.The procedure involved the enzymatic hydrolysis of 3 mL urine samples followed by solid-phase extraction using HF Bond Elut C18 cartridge. The resulting extracts were then separated on a C18 reversed-phase column and analyzed using liquid chromatography/high-resolution mass spectrometry (LC/HRMS) in both electrospray ionization positive and negative modes in two separate injections. The analytical data were obtained in full scan and product ion scan (PIS) modes in an 11 min LC run.METHODSThe procedure involved the enzymatic hydrolysis of 3 mL urine samples followed by solid-phase extraction using HF Bond Elut C18 cartridge. The resulting extracts were then separated on a C18 reversed-phase column and analyzed using liquid chromatography/high-resolution mass spectrometry (LC/HRMS) in both electrospray ionization positive and negative modes in two separate injections. The analytical data were obtained in full scan and product ion scan (PIS) modes in an 11 min LC run.The method can detect 1011 compounds (in both positive and negative ion modes). Over 95% of the target compounds have limits of detections (LODs) ≤10 ng/mL, and more than 50% of the LODs are ≤0.5 ng/mL. The lowest LOD can reach down to 0.01 ng/mL. The applicability of the method was demonstrated by the successful detection of prohibited substances in overseas and domestic equine urine samples.RESULTSThe method can detect 1011 compounds (in both positive and negative ion modes). Over 95% of the target compounds have limits of detections (LODs) ≤10 ng/mL, and more than 50% of the LODs are ≤0.5 ng/mL. The lowest LOD can reach down to 0.01 ng/mL. The applicability of the method was demonstrated by the successful detection of prohibited substances in overseas and domestic equine urine samples.We have successfully developed a regular screening method for equine urine samples that can detect more than 1000 compounds at sub-ppb levels in both positive and negative ion modes with full scan and PIS using LC/HRMS. Furthermore, this method can theoretically be expanded to accommodate an unlimited number of prohibited substances in full-scan mode.CONCLUSIONSWe have successfully developed a regular screening method for equine urine samples that can detect more than 1000 compounds at sub-ppb levels in both positive and negative ion modes with full scan and PIS using LC/HRMS. Furthermore, this method can theoretically be expanded to accommodate an unlimited number of prohibited substances in full-scan mode.
RationaleTo uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening method to cover a wide range of target substances at the required detection levels in equine urine.MethodsThe procedure involved the enzymatic hydrolysis of 3 mL urine samples followed by solid‐phase extraction using HF Bond Elut C18 cartridge. The resulting extracts were then separated on a C18 reversed‐phase column and analyzed using liquid chromatography/high‐resolution mass spectrometry (LC/HRMS) in both electrospray ionization positive and negative modes in two separate injections. The analytical data were obtained in full scan and product ion scan (PIS) modes in an 11 min LC run.ResultsThe method can detect 1011 compounds (in both positive and negative ion modes). Over 95% of the target compounds have limits of detections (LODs) ≤10 ng/mL, and more than 50% of the LODs are ≤0.5 ng/mL. The lowest LOD can reach down to 0.01 ng/mL. The applicability of the method was demonstrated by the successful detection of prohibited substances in overseas and domestic equine urine samples.ConclusionsWe have successfully developed a regular screening method for equine urine samples that can detect more than 1000 compounds at sub‐ppb levels in both positive and negative ion modes with full scan and PIS using LC/HRMS. Furthermore, this method can theoretically be expanded to accommodate an unlimited number of prohibited substances in full‐scan mode.
Author Uchida, Taiga
Kisugi, Takaya
Ishii, Hideaki
Yamada, Masayuki
Leung, Gary Ngai‐Wa
Kinoshita, Kenji
Author_xml – sequence: 1
  givenname: Taiga
  orcidid: 0000-0001-8280-2602
  surname: Uchida
  fullname: Uchida, Taiga
  email: t-uchida@lrc.or.jp
  organization: Laboratory of Racing Chemistry
– sequence: 2
  givenname: Takaya
  surname: Kisugi
  fullname: Kisugi, Takaya
  email: t-kisugi@lrc.or.jp
  organization: Laboratory of Racing Chemistry
– sequence: 3
  givenname: Hideaki
  orcidid: 0000-0002-6850-1894
  surname: Ishii
  fullname: Ishii, Hideaki
  organization: Laboratory of Racing Chemistry
– sequence: 4
  givenname: Masayuki
  surname: Yamada
  fullname: Yamada, Masayuki
  organization: Laboratory of Racing Chemistry
– sequence: 5
  givenname: Kenji
  surname: Kinoshita
  fullname: Kinoshita, Kenji
  organization: Laboratory of Racing Chemistry
– sequence: 6
  givenname: Gary Ngai‐Wa
  orcidid: 0000-0002-6949-5721
  surname: Leung
  fullname: Leung, Gary Ngai‐Wa
  organization: Laboratory of Racing Chemistry
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38945695$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1q3DAQgEVJaTZpoU9QBL304mRkW7J1bJf-QUqgtGejyOO1giU5kpWytz5CD33CPkm1u0kKhVw0MHyjb35OyJHzDgl5yeCMAZTnQdsz2XLxhKwYyKaAsmJHZAWSs6Jmsj0mJzFeAzDGS3hGjqtW1lxIviK_3wWv-j8_f8UZ9RKSpcr1NKKLZjG3SKMOiM64DfUDtT4gXUblaLYC1d7OPrk-UuMo3iTjkKawf-OuYjI511M9Bm_V4jdBzeP2fDSbMfsCRj-lxXhHrYqRHvze4hK2z8nTQU0RX9zFU_L9w_tv60_FxeXHz-u3F4WuGIhCNqzOI0LfCKh0v1uAwoENjWhaAXyf1C2WvC6bWmnBmBRClS2XPbsqoapOyZvDv3PwNwnj0lkTNU6TcuhT7CpoalZx4E1GX_-HXvsUXO4uU7JkkI11pl7dUenKYt_NwVgVtt39vv8ZdfAxBhweEAbd7pRdPmW3mySjxQH9YSbcPsp1X9df9vxfTRChfQ
Cites_doi 10.1002/dta.2896
10.1016/j.chroma.2017.10.043
10.1016/j.chroma.2014.05.010
10.1007/s00216‐012‐5972‐0
10.1016/j.aca.2017.07.005
10.1016/j.jchromb.2014.03.018
10.1016/j.chroma.2016.11.032
10.1016/j.jchromb.2015.06.020
10.1002/dta.1395
10.1039/c2an15662h
10.1093/jat/bku095
10.1007/s00216‐012‐6697‐9
10.1007/s00216‐010‐3455‐8
10.1002/dta.1737
10.1016/j.aca.2011.01.006
10.1021/ac070135o
10.1039/d0ay02297g
10.1002/dta.2671
10.1016/j.jchromb.2013.10.008
10.1002/dta.2880
10.1002/dta.2191
10.1016/j.ijms.2012.06.009
10.1002/dta.2892
10.1002/dta.3544
10.1002/dta.3353
10.1002/rcm.3712
10.1021/ac801234f
10.1002/dta.1719
ContentType Journal Article
Copyright 2024 John Wiley & Sons Ltd.
2024 John Wiley & Sons, Ltd.
Copyright_xml – notice: 2024 John Wiley & Sons Ltd.
– notice: 2024 John Wiley & Sons, Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7SR
7U5
8BQ
8FD
JG9
JQ2
L7M
7X8
DOI 10.1002/rcm.9856
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Engineered Materials Abstracts
Solid State and Superconductivity Abstracts
METADEX
Technology Research Database
Materials Research Database
ProQuest Computer Science Collection
Advanced Technologies Database with Aerospace
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Materials Research Database
Engineered Materials Abstracts
Technology Research Database
ProQuest Computer Science Collection
Solid State and Superconductivity Abstracts
Advanced Technologies Database with Aerospace
METADEX
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Materials Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1097-0231
EndPage 1593
ExternalDocumentID 38945695
10_1002_rcm_9856
RCM9856
Genre article
Journal Article
GrantInformation_xml – fundername: Japan Racing Association
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHQN
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCZN
ACGFS
ACIWK
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AIDQK
AIDYY
AITYG
AIURR
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AQPKS
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LH5
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
RNS
ROL
RX1
RYL
SAMSI
SUPJJ
TN5
UB1
V2E
W8V
W99
WBFHL
WBKPD
WH7
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRJ
WXSBR
WYISQ
XG1
XPP
XV2
ZCG
ZZTAW
~02
~IA
~WT
AAYXX
CITATION
AAHHS
ACCFJ
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
CGR
CUY
CVF
ECM
EIF
NPM
RWI
WRC
7SR
7U5
8BQ
8FD
JG9
JQ2
L7M
7X8
ID FETCH-LOGICAL-c3106-97140950d7603cd9856aef1f7678605603cdc8e254274ac611966a2859d1b2033
IEDL.DBID DR2
ISSN 0951-4198
1097-0231
IngestDate Thu Jul 10 21:35:34 EDT 2025
Fri Jul 25 12:24:11 EDT 2025
Wed Feb 19 02:06:22 EST 2025
Wed Aug 27 16:40:56 EDT 2025
Sun Jul 06 04:45:32 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 17
Language English
License 2024 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3106-97140950d7603cd9856aef1f7678605603cdc8e254274ac611966a2859d1b2033
Notes Taiga Uchida and Takaya Kisugi have contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6850-1894
0000-0002-6949-5721
0000-0001-8280-2602
PMID 38945695
PQID 3092108604
PQPubID 1016428
PageCount 11
ParticipantIDs proquest_miscellaneous_3074135057
proquest_journals_3092108604
pubmed_primary_38945695
crossref_primary_10_1002_rcm_9856
wiley_primary_10_1002_rcm_9856_RCM9856
PublicationCentury 2000
PublicationDate 2024-09-15
PublicationDateYYYYMMDD 2024-09-15
PublicationDate_xml – month: 09
  year: 2024
  text: 2024-09-15
  day: 15
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Bognor Regis
PublicationSubtitle RCM
PublicationTitle Rapid communications in mass spectrometry
PublicationTitleAlternate Rapid Commun Mass Spectrom
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2014; 958
2013; 405
2019; 11
2013; 941
2017; 1526
2020; 12
2024; 16
2013; 5
2012; 403
2015; 7
2007; 79
2017; 9
2021; 13
2012; 325‐327
2015; 998‐999
2011; 700
2023
2010; 396
2014; 38
2016; 1478
2022; 14
2008; 22
2014; 1357
2012; 137
2017; 985
2008; 80
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_27_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_12_1
e_1_2_8_30_1
References_xml – volume: 1526
  start-page: 1
  year: 2017
  end-page: 12
  article-title: Data acquisition workflows in liquid chromatography coupled to high resolution mass spectrometry‐based metabolomics: where do we stand?
  publication-title: J Chromatogr A
– volume: 396
  start-page: 2513
  issue: 7
  year: 2010
  end-page: 2521
  article-title: Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol‐epoetin beta in equine plasma by nano‐liquid chromatography‐tandem mass spectrometry
  publication-title: Anal Bioanal Chem
– volume: 79
  start-page: 4627
  issue: 12
  year: 2007
  end-page: 4635
  article-title: LC‐MS/MS method for confirmation of recombinant human erythropoietin and darbepoetin alpha in equine plasma
  publication-title: Anal Chem
– volume: 12
  start-page: 1274
  issue: 9
  year: 2020
  end-page: 1286
  article-title: Detection of bioactive peptides including gonadotrophin‐releasing factors (GnRHs) in horse urine using ultra‐high performance liquid chromatography‐high resolution mass spectrometry (UHPLC/HRMS)
  publication-title: Drug Test Anal
– volume: 941
  start-page: 69
  year: 2013
  end-page: 80
  article-title: A generic screening methodology for horse doping control by LC‐TOF‐MS, GC‐HRMS and GC‐MS
  publication-title: J Chromatogr B Analyt Technol Biomed Life Sci
– volume: 38
  start-page: 536
  issue: 8
  year: 2014
  end-page: 540
  article-title: Equine total carbon dioxide testing in Illinois in 2012
  publication-title: J Anal Toxicol
– volume: 11
  start-page: 1308
  issue: 9
  year: 2019
  end-page: 1325
  article-title: A comprehensive approach to detecting multitudinous bioactive peptides in equine plasma and urine using hydrophilic interaction liquid chromatography coupled to high resolution mass spectrometry
  publication-title: Drug Test Anal
– volume: 325‐327
  start-page: 80
  year: 2012
  end-page: 85
  article-title: Orbitrap mass spectrometry with resolving powers above 1,000,000
  publication-title: International Journal of Mass Spectrometry
– volume: 12
  start-page: 1452
  issue: 10
  year: 2020
  end-page: 1461
  article-title: An innovative derivatization‐free IC‐MS/MS method for the detection of bisphosphonates in horse plasma
  publication-title: Drug Test Anal
– volume: 80
  start-page: 8340
  issue: 21
  year: 2008
  end-page: 8347
  article-title: Identification of recombinant equine growth hormone in horse plasma by LC‐MS/MS: a confirmatory analysis in doping control
  publication-title: Anal Chem
– volume: 1357
  start-page: 36
  year: 2014
  end-page: 52
  article-title: Core‐shell particles: preparation, fundamentals and applications in high performance liquid chromatography
  publication-title: J Chromatogr A
– volume: 7
  start-page: 619
  issue: 7
  year: 2015
  end-page: 625
  article-title: Pharmacokinetics and selected pharmacodynamics of cobalt following a single intravenous administration to horses
  publication-title: Drug Test Anal
– volume: 5
  start-page: 509
  issue: 7
  year: 2013
  end-page: 528
  article-title: High resolution accurate mass screening of prohibited substances in equine plasma using liquid chromatography—orbitrap mass spectrometry
  publication-title: Drug Test Anal
– volume: 13
  start-page: 1565
  issue: 13
  year: 2021
  end-page: 1575
  article-title: Use of high resolution/accurate mass full scan/data‐dependent acquisition for targeted/non‐targeted screening in equine doping control
  publication-title: Anal Methods
– volume: 1478
  start-page: 35
  year: 2016
  end-page: 42
  article-title: Simultaneous detection of recombinant growth hormones in equine plasma by liquid chromatography/high‐resolution tandem mass spectrometry for doping control
  publication-title: J Chromatogr A
– volume: 958
  start-page: 108
  year: 2014
  end-page: 116
  article-title: HPLC/ESI‐MS(n) method for non‐amino bisphosphonates: application to the detection of tiludronate in equine plasma
  publication-title: J Chromatogr B Analyt Technol Biomed Life Sci
– volume: 16
  start-page: 406
  issue: 4
  year: 2024
  end-page: 419
  article-title: Detection of doping peptides and basic drugs in equine urine using liquid chromatography‐mass spectrometry
  publication-title: Drug Test Anal
– volume: 14
  start-page: 1724
  issue: 10
  year: 2022
  end-page: 1731
  article-title: A fully automated method to quantitate total carbon dioxide in equine plasma by headspace GCMS
  publication-title: Drug Test Anal
– volume: 998‐999
  start-page: 1
  year: 2015
  end-page: 7
  article-title: Liquid chromatography‐mass spectrometry analysis of five bisphosphonates in equine urine and plasma
  publication-title: J Chromatogr B Analyt Technol Biomed Life Sci
– volume: 12
  start-page: 1462
  issue: 10
  year: 2020
  end-page: 1469
  article-title: Doping control analysis of total arsenic in equine plasma
  publication-title: Drug Test Anal
– volume: 403
  start-page: 1619
  issue: 6
  year: 2012
  end-page: 1628
  article-title: Detection of recombinant human EPO administered to horses using MAIIA lateral flow isoform test
  publication-title: Anal Bioanal Chem
– volume: 22
  start-page: 3130
  issue: 20
  year: 2008
  end-page: 3136
  article-title: Direct determination of recombinant bovine somatotropin in plasma from a treated goat by liquid chromatography/high‐resolution mass spectrometry
  publication-title: Rapid Commun Mass Spectrom
– year: 2023
– volume: 985
  start-page: 79
  year: 2017
  end-page: 90
  article-title: Comprehensive solid‐phase extraction of multitudinous bioactive peptides from equine plasma and urine for doping detection
  publication-title: Anal Chim Acta
– volume: 9
  start-page: 1400
  issue: 9
  year: 2017
  end-page: 1406
  article-title: Interlaboratory trial for the measurement of total cobalt in equine urine and plasma by ICP‐MS
  publication-title: Drug Test Anal
– volume: 700
  start-page: 126
  issue: 1–2
  year: 2011
  end-page: 136
  article-title: Use of benchtop exactive high resolution and high mass accuracy orbitrap mass spectrometer for screening in horse doping control
  publication-title: Anal Chim Acta
– volume: 405
  start-page: 2595
  issue: 8
  year: 2013
  end-page: 2606
  article-title: Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography‐mass spectrometry
  publication-title: Anal Bioanal Chem
– volume: 137
  start-page: 2445
  issue: 10
  year: 2012
  end-page: 2453
  article-title: A new analytical method based on anti‐EPO monolith column and LC‐FAIMS‐MS/MS for the detection of rHuEPOs in horse plasma and urine samples
  publication-title: Analyst
– volume: 7
  start-page: 21
  issue: 1
  year: 2015
  end-page: 30
  article-title: Controlling the misuse of cobalt in horses
  publication-title: Drug Test Anal
– ident: e_1_2_8_22_1
  doi: 10.1002/dta.2896
– ident: e_1_2_8_3_1
– ident: e_1_2_8_25_1
  doi: 10.1016/j.chroma.2017.10.043
– ident: e_1_2_8_31_1
  doi: 10.1016/j.chroma.2014.05.010
– ident: e_1_2_8_14_1
  doi: 10.1007/s00216‐012‐5972‐0
– ident: e_1_2_8_8_1
  doi: 10.1016/j.aca.2017.07.005
– ident: e_1_2_8_32_1
– ident: e_1_2_8_4_1
  doi: 10.1016/j.jchromb.2014.03.018
– ident: e_1_2_8_18_1
  doi: 10.1016/j.chroma.2016.11.032
– ident: e_1_2_8_5_1
  doi: 10.1016/j.jchromb.2015.06.020
– ident: e_1_2_8_2_1
– ident: e_1_2_8_28_1
  doi: 10.1002/dta.1395
– ident: e_1_2_8_15_1
  doi: 10.1039/c2an15662h
– ident: e_1_2_8_23_1
  doi: 10.1093/jat/bku095
– ident: e_1_2_8_7_1
  doi: 10.1007/s00216‐012‐6697‐9
– ident: e_1_2_8_13_1
  doi: 10.1007/s00216‐010‐3455‐8
– ident: e_1_2_8_19_1
  doi: 10.1002/dta.1737
– ident: e_1_2_8_27_1
  doi: 10.1016/j.aca.2011.01.006
– ident: e_1_2_8_12_1
  doi: 10.1021/ac070135o
– ident: e_1_2_8_30_1
  doi: 10.1039/d0ay02297g
– ident: e_1_2_8_9_1
  doi: 10.1002/dta.2671
– ident: e_1_2_8_29_1
  doi: 10.1016/j.jchromb.2013.10.008
– ident: e_1_2_8_10_1
  doi: 10.1002/dta.2880
– ident: e_1_2_8_21_1
  doi: 10.1002/dta.2191
– ident: e_1_2_8_26_1
  doi: 10.1016/j.ijms.2012.06.009
– ident: e_1_2_8_6_1
  doi: 10.1002/dta.2892
– ident: e_1_2_8_11_1
  doi: 10.1002/dta.3544
– ident: e_1_2_8_24_1
  doi: 10.1002/dta.3353
– ident: e_1_2_8_17_1
  doi: 10.1002/rcm.3712
– ident: e_1_2_8_16_1
  doi: 10.1021/ac801234f
– ident: e_1_2_8_20_1
  doi: 10.1002/dta.1719
SSID ssj0011520
Score 2.4367769
Snippet Rationale To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive...
To uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive screening...
RationaleTo uphold the integrity of horseracing and equestrian sports, it is critical for an equine doping control laboratory to develop a comprehensive...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 1
SubjectTerms Animals
Chromatography
Chromatography, Liquid - methods
Column chromatography
Doping in Sports - prevention & control
Horses - urine
Limit of Detection
Liquid chromatography
Mass spectrometry
Mass Spectrometry - methods
Negative ions
Reproducibility of Results
Scientific imaging
Screening
Solid Phase Extraction - methods
Substance Abuse Detection - methods
Substance Abuse Detection - veterinary
Target detection
Urine
Title Broad‐spectrum and sensitive screening of more than 1000 compounds in equine urine using liquid chromatography/high‐resolution mass spectrometry
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Frcm.9856
https://www.ncbi.nlm.nih.gov/pubmed/38945695
https://www.proquest.com/docview/3092108604
https://www.proquest.com/docview/3074135057
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA7iRS--H-uLEcRbd9M0aZujLIoIehAFwUNJmxRFt9Vd9-LJn-DBX-gvcaaPFRVBvLSQpp2888108g1je3kWxjh0rKdMGnvSt8pLI809p4QMuNM2l3R2-PQsPL6UJ1fqqvGqpLMwNT_ExOBGM6Nar2mCm3TU-yQNHWaDro4VsW2TqxbhofMJcxTinJqRkaLIS1SsW95ZLnrti193oh_w8itarbabo3l23Ra09jK5646f0m72_I3D8X81WWBzDQqFg3rYLLIpVyyxmX4b_G2ZvaF6buz7y2t1EnM4HoApLIzI253WR8DFBhVg3PagzIF8dYFM8EBmfCAvdQrWNILbAtzjGMsHZNPHKxkm4P4W0yxkN8MS4XJDmd0j3mSUh9p_MxlggLgeavnlwGGxVtjl0eFF_9hrAjh4GaLG0NPEBqgVt1HIg8xSHY3L_TzCHRLVqCoxix3qqKgbmyz0cTkIDVHqWT8VPAhW2XRRFm6dgZFGqFzYOMqV9I2JuUhlFCkteG6V1R2223Zm8lDzdCQ1I7NIsH0Tkt1hW20vJ81MHSUB14KiTXGJn5g8xtamHyemcOWY8iDuCkiV67C1enRMhCDgQwyqVYftV338q_TkvH9K942_ZtxkswIRFDmn-GqLTWNnu21EQE_pTjXWPwBFVAWu
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtNAEB5V5VAu_P8ECgwScHOy3uza3gMHSKlS2vRQtVJvZu1diwpig9MIwYlH4MBb8Co8BU_CjH-CCkLi0gOXRLKdjDU7M_vN7uw3AI-KPErIdFygbZYEKnQ6yGIjAq-lGgtvXKH47PBsP5oeqZfH-ngNvvVnYVp-iNWCG3tGE6_ZwXlBevSLNbTO50OT6KirqNz1Hz9QvrZ4urNFg_tYyu0Xh5Np0LUUCHLCMVFgmJ_OaOHiSIxzxz-3vgiLmGI2AfvmYp54ypooW7N5FJKBRpZJ3lyYScGrnxTvL3ADcSbq3zpYcVURsmo5ILlvvaJUvme6FXLUv-nZue8PQHsWHzcT3PZl-N6rpq1reTNcnmbD_NNvrJH_ie6uwKUOaOOz1jOuwpovr8HGpO9vdx2-Pq8r6358_tIcNq2Xc7SlwwUX9PMUgBRPKcenmR2rArkcGXmXAXmnArkQn_tRLfCkRP9-SQpB3ragT157wbcndM1h_rquKCPoWMFHTA1N8mrf-zvOKXXBVn419_RaN-DoXJRyE9bLqvS3Aa2yUhfSJXGhVWhtImSm4lgbKQqnnRnAw9560nctFUnakk7LlMYzZdkD2OzNKu2C0SIdCyO5oZZQ9Ber26Rt3huypa-W_AxByzFnqwO41ZrjSghhWoLZRg_gSWNUf5WeHkxm_H3nXx98ABvTw9leurezv3sXLkoCjFyLE-pNWKeB9_cI8J1m9xtHQ3h13tb5E4VmXoA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtNAEB5VRQIu_P8ECgwScHOy3uza3gMHSIhaSitUUak3s_auRQWxi9MIwYlH4MBT8Cq8BU_CjH-CCkLi0gOXRLKdjDU7M_vN7uw3AA-KPErIdFygbZYEKnQ6yGIjAq-lGgtvXKH47PDObrS5r54f6IM1-NafhWn5IVYLbuwZTbxmBz9yxegXaWidz4cm0VFXULntP36gdG3xeGtKY_tQytmzV5PNoOsoEOQEY6LAMD2d0cLFkRjnjn9ufREWMYVswvXNxTzxlDRRsmbzKCT7jCxzvLkwk4IXPyncn1GRMNwmYrq3oqoiYNVSQHLbekWZfE90K-Sof9OTU98fePYkPG7mt9lF-N5rpi1reTtcHmfD_NNvpJH_h-ouwYUOZuOT1i8uw5ovr8C5Sd_d7ip8fVpX1v34_KU5alov52hLhwsu5-cJACmaUoZP8zpWBXIxMvIeA_I-BXIZPnejWuBhif79kvSBvGlBn7zygu8O6ZrD_E1dUT7QcYKPmBia5NW-93acU-KCrfxq7um1rsH-qSjlOqyXVelvAlplpS6kS-JCq9DaRMhMxbE2UhROOzOA-73xpEctEUnaUk7LlMYzZdkD2OitKu1C0SIdCyO5nZZQ9Ber26Rt3hmypa-W_AwByzHnqgO40VrjSgghWgLZRg_gUWNTf5We7k12-PvWvz54D86-nM7SF1u727fhvCS0yIU4od6AdRp3f4fQ3nF2t3EzhNenbZw_AfHhXS8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Broad-spectrum+and+sensitive+screening+of+more+than+1000+compounds+in+equine+urine+using+liquid+chromatography%2Fhigh-resolution+mass+spectrometry&rft.jtitle=Rapid+communications+in+mass+spectrometry&rft.au=Uchida%2C+Taiga&rft.au=Kisugi%2C+Takaya&rft.au=Ishii%2C+Hideaki&rft.au=Yamada%2C+Masayuki&rft.date=2024-09-15&rft.eissn=1097-0231&rft.volume=38&rft.issue=17&rft.spage=e9856&rft_id=info:doi/10.1002%2Frcm.9856&rft_id=info%3Apmid%2F38945695&rft.externalDocID=38945695
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0951-4198&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0951-4198&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0951-4198&client=summon